Fig. 8From: Establishment and evaluation of glucose-modified nanocomposite liposomes for the treatment of cerebral malariaA The fluorescence images of mice treated with iv-DiR@ATS/TMP@lipoBX (brain-targeted liposomes). B The fluorescence images of mice treated with na-DiR@ATS/TMP@lipoBX and na-DiR@ATS/TMP@lipo (non-targeted liposomes), respectively. C The fluorescence images of the brain of mice treated with iv-DiR@ATS/TMP@lipoBX, na-DiR@ATS/TMP@lipoBX and na-DiR@ATS/TMP@lipo, respectively; D the Fluorescence quantity of iv-DiR@ATS/TMP@lipoBX, na-DiR@ATS/TMP@lipoBX and na-DiR@ATS/TMP@lipo, respectively (n = 3)Back to article page